AN2 Therapeutics, Inc. (ANTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.97
Day's range
$6.91

AN2 Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ALMITAS CAPITAL LLC 02/17/2026 1.48 M $1.69 M   3.56% 4.89%
VANGUARD GROUP INC 01/29/2026 1.08 M $1.23 M   0.00% 3.57%
PFIZER INC 02/12/2026 715.30 K $815.44 K   0.00% 2.36%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 627.67 K $715.54 K   11.31% 2.07%
PEAPOD LANE CAPITAL LLC 01/28/2026 593.40 K $676.47 K   0.71% 1.96%
BANK OF NOVA SCOTIA 02/13/2026 459.19 K $523.48 K   0.00% 1.52%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 02/13/2026 431.76 K $492.21 K   -5.41% 1.43%
BANK OF MONTREAL /CAN/ 02/12/2026 422.08 K $481.17 K   0.00% 1.39%
BANK OF AMERICA CORP /DE/ 02/17/2026 385.31 K $439.26 K   0.00% 1.27%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 338.60 K $386.00 K   -12.19% 1.12%
BLACKROCK, INC. 02/12/2026 323.34 K $368.60 K   0.76% 1.07%
TWO SIGMA ADVISERS, LP 02/17/2026 264.90 K $301.99 K   -1.12% 0.87%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 251.88 K $287.20 K   1.01% 0.83%
MORGAN STANLEY 02/13/2026 229.77 K $261.94 K   20.44% 0.76%
TWO SIGMA INVESTMENTS, LP 02/17/2026 178.52 K $203.51 K   -20.07% 0.59%
WOODLINE PARTNERS LP 02/17/2026 145.97 K $166.41 K   100.00% 0.48%
CITADEL ADVISORS LLC 02/17/2026 115.54 K $131.71 K   402.05% 0.38%
MILLENNIUM MANAGEMENT LLC 02/17/2026 95.68 K $109.08 K   100.00% 0.32%
STATE STREET CORP 02/13/2026 87.00 K $99.18 K   0.00% 0.29%
RANGELEY CAPITAL, LLC 02/17/2026 65.00 K $74.10 K   0.00% 0.21%
SQUAREPOINT OPS LLC 02/13/2026 61.61 K $70.24 K   -4.13% 0.20%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 59.90 K $68.29 K   0.00% 0.20%
UBS GROUP AG 01/29/2026 56.67 K $64.60 K   -0.05% 0.19%
NORTHERN TRUST CORP 02/17/2026 43.20 K $49.24 K   0.00% 0.14%
CAPTRUST FINANCIAL ADVISORS 02/17/2026 40.00 K $45.60 K   0.00% 0.13%
PRIVATE ADVISOR GROUP, LLC 02/17/2026 22.50 K $25.65 K   0.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 22.24 K $25.35 K   100.00% 0.07%
JANE STREET GROUP, LLC 02/12/2026 17.94 K $20.45 K   100.00% 0.06%
SCHONFELD STRATEGIC ADVISORS LLC 02/17/2026 14.28 K $16.28 K   0.00% 0.05%
FEDERATED HERMES, INC. 02/12/2026 11.48 K $13.09 K   -3.39% 0.04%
VALEO FINANCIAL ADVISORS, LLC 02/04/2026 10.45 K $11.91 K   100.00% 0.03%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 10.18 K $11.61 K   0.00% 0.03%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 2.04 K $2.33 K   -4.14% 0.01%
FMR LLC 02/17/2026 1.20 K $1.37 K   20.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 303 $345   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 300 $342   0.00% 0.00%
SBI SECURITIES CO., LTD. 02/03/2026 200 $228   0.00% 0.00%
XTX TOPCO LTD 02/17/2026 0 $0   -100.00% 0.00%
ACT ADVISORS, LLC. 01/14/2026 0 $0   -100.00% 0.00%
HIGHLINE WEALTH PARTNERS LLC 01/15/2026 0 $0   -100.00% 0.00%

AN2 Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 48 institutional investors and hedge funds held shares of AN2 Therapeutics Inc. The most heavily invested institutionals were:

JANE STREET GROUP, LLC: 303,649

LANDSCAPE CAPITAL MANAGEMENT, L.L.C.: 298,166

VANGUARD FIDUCIARY TRUST CO: 137,708

UBS Group AG: 61,392

Peapod Lane Capital LLC: 59,854

Persistent Asset Partners Ltd: 38,155

28.62% of AN2 Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 8.55 M shares in the last 24 months. This purchase volume represents approximately $44.88 M in transactions.